XML 77 R42.htm IDEA: XBRL DOCUMENT v3.22.4
Agreements with Royalty Pharma - Schedule of Future Minimum Payments under Term Loan Agreement (Detail)
$ in Thousands
Dec. 31, 2022
USD ($)
Debt Instrument [Line Items]  
2023 $ 10,295
2024 19,745
2025 19,745
2026 40,878
2027 558,900
Less: Unamortized interest and loan costs (15,324)
Term Loan, net 649,563
RP Loan Agreement [Member]  
Debt Instrument [Line Items]  
2023 1,440
2024 10,080
2025 11,520
2026 11,520
2027 11,520
Thereafter 48,960
Future minimum payments 95,040
Less: Unamortized interest and loan costs (30,272)
Term Loan, net $ 64,768